RHHBY - Roche Holding AG

Other OTC - Other OTC Delayed Price. Currency in USD
32.48
-0.21 (-0.64%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close32.69
Open32.75
Bid0.00 x 0
Ask0.00 x 0
Day's Range32.46 - 32.89
52 Week Range26.30 - 34.98
Volume834,538
Avg. Volume1,095,819
Market Cap224.358B
Beta (3Y Monthly)0.50
PE Ratio (TTM)21.16
EPS (TTM)1.54
Earnings DateN/A
Forward Dividend & Yield1.07 (3.12%)
Ex-Dividend Date2019-03-07
1y Target Est35.55
Trade prices are not sourced from all markets
  • Is a Beat in Store for AbbVie (ABBV) This Earnings Season?
    Zacks10 hours ago

    Is a Beat in Store for AbbVie (ABBV) This Earnings Season?

    Strong growth of Imbruvica and Mavyret are expected to drive AbbVie (ABBV) first-quarter sales. Declining ex-U.S. Humira sales are likely to be an overhang on the top line.

  • Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
    Zacks4 days ago

    Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs

    Roche's (RHHBY) performance in the first quarter of 2019 is driven by solid strength of new drugs, which more than offset competition from biosimilars.

  • Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted
    Investor's Business Daily5 days ago

    Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted

    Ionis Pharmaceuticals was slammed Wednesday on competitive gene-therapy data from Novartis' AveXis unit and amid apparently disappointing comments from Roche in Huntington's disease.

  • Here's Why Ionis Pharmaceuticals Slumped Today
    Motley Fool5 days ago

    Here's Why Ionis Pharmaceuticals Slumped Today

    Information from competitors and a collaborator sent the high-flying biotech lower.

  • Benzinga6 days ago

    The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 16) Eidos Therapeutics Inc (NASDAQ: EIDX )(reported fourth ...

  • Reuters6 days ago

    Swiss drugmaker Roche ups outlook as sales growth offsets price hit

    By John Miller ZURICH (Reuters) - Swiss drugmaker Roche lifted its 2019 outlook on Wednesday, as sales growth in China and the United States outpaced price declines it has suffered amid President Donald ...

  • Reuters6 days ago

    Roche sees no Brexit interruption for patients

    Roche holding ag ceo says sales growth for hemlibra primarily driven by non-inhibitors patients Roche holding ag ceo says spark therapeutics acquisition planned to be completed in first half Roche holding ...

  • Financial Times6 days ago

    Roche raises 2019 outlook on strong first quarter

    Roche, the Swiss drugmaker, has raised its full-year sales outlook on strong sales growth for the first three months of 2019. The company said it now expects mid-single digits sales growth for 2019 from low to mid-single digit range as forecast at the end of January. “We have started the year with strong sales growth, driven by the newly launched products in our Pharmaceuticals Division,” said Roche chief executive Severin Schwan.

  • GlobeNewswire6 days ago

    Roche reports a strong start in 2019 and raises the outlook for the full-year

    Basel, 17 April 2019 Group sales increase 8% 1 at constant exchange rates and 9% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Perjeta, Hemlibra and Tecentriq Diagnostics ...

  • Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA
    Zacks6 days ago

    Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA

    The FDA accepts Novartis' (NVS) BLA seeking approval for brolucizumab for the treatment of wet AMD.

  • Bristol-Myers' Shareholders Vote for Celgene Acquisition
    Zacks7 days ago

    Bristol-Myers' Shareholders Vote for Celgene Acquisition

    Bristol-Myers' (BMY) gets a green signal from a majority of its shareholders for the merger with Celgene Corporation.

  • Ophthotech Gets Rights to Gene Therapy for BEST Disease
    Zacks10 days ago

    Ophthotech Gets Rights to Gene Therapy for BEST Disease

    Ophthotech (OPHT) obtains development/commercialization rights to AAV gene-therapy program for BEST1-related retinal diseases from Penn and UFRF.

  • Biotechnology Market on a Tear: 5 ETFs in Spotlight
    Zacks11 days ago

    Biotechnology Market on a Tear: 5 ETFs in Spotlight

    Increasing M&A deals, growing AI dominance and favorable regulatory tidings continue to accelerate the biotech market. Accordingly, ETFs with exposure to the sector continue to shine.

  • Benzinga12 days ago

    Cannabis Securities Trading on The OTC Markets Saw Dramatic Volume Increases In March

    Even in what has been a notoriously high-volume sector, March was a particularly strong month for cannabis securities that trade on OTC Markets.  Six of the top 10 most active securities in March on the ...

  • J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?
    Zacks12 days ago

    J&J (JNJ) to Kick-start Pharma Q1 Earnings: What's in Store?

    J&J's (JNJ) sales growth in first-quarter 2019 is expected to be hurt by generic/biosimilar headwinds in the Pharma unit.

  • Blink Health CEO weighs in on drug pricing
    Yahoo Finance Video8 hours ago

    Blink Health CEO weighs in on drug pricing

    A new study from the Organization for Economic Co-operation and Development found that Americans spend an average of 1,200 dollars on prescription drugs per a year. Blink Health CEO talks to Yahoo Finance's YFi AM his plans to lower prescription pricing for patients at more than 35,000 pharmacies across the United States.

  • Walmart teams with Kidbox for clothing subscription service
    Yahoo Finance Video5 days ago

    Walmart teams with Kidbox for clothing subscription service

    Walmart is stepping into the subscription box space. The retailer is teaming up with Kidbox to deliver curated clothing boxes to its customers, including such brands as Miniville, Material Girl, Jessica Simpson and Chickpea. Yahoo Finance's Dan Roberts, Kristin Myers, and Julia La Roche sat down with Kidbox's CEO Miki Berardelli to discuss the partnership.

  • Walmart partners with KIDBOX for style subscription delivery for kids
    Yahoo Finance Video6 days ago

    Walmart partners with KIDBOX for style subscription delivery for kids

    Walmart is partnering with Kidbox to launch a subscription delivery box for kids. Yahoo Finance's Julia La Roche and Alexis Christoforous discuss.

  • Goldman Sachs posts mixed Q1 results, sees drop in trading revenue
    Yahoo Finance Video7 days ago

    Goldman Sachs posts mixed Q1 results, sees drop in trading revenue

    Yahoo Finance's Akiko Fujita and Julia La Roche discuss Goldman Sachs Q1 earnings.

  • JPMorgan earnings beat expectations, stock jumps
    Yahoo Finance Video10 days ago

    JPMorgan earnings beat expectations, stock jumps

    JPMorgan Chase posted adjusted earnings per share of $2.65, versus analysts’ forecasts of $2.35 for the first quarter Friday. Yahoo Finance’s Julia La Roche and Alexis Christoforous break down the details.

  • Jeff Bezos makes the case for why Amazon is tiny in retail
    Yahoo Finance Video11 days ago

    Jeff Bezos makes the case for why Amazon is tiny in retail

    Jeff Bezos is out with his annual letter to Amazon shareholders, which started with "Third-party sellers are kicking out first party butt.' Yahoo Finance's Seana Smith and Julia La Roche discuss.

  • IRS changes to W-4 could make more work for taxpayers
    Yahoo Finance Video12 days ago

    IRS changes to W-4 could make more work for taxpayers

    The IRS plans to release a new W-4 form that would make the tax withholdings in your paychecks more accurate, better reflecting the new tax law, but the changes could leave you with more paperwork. The goal is to get taxpayers to net zero by the time April rolls around, meaning they wouldn't owe or be owed any money. The head of government affairs at ADP told USA Today that "The accuracy will be 100 percent, but the ease-of-use will be zero.” Yahoo Finance’s Melody Hahm, Myles Udland, and Julia La Roche discuss their takes on the form changes and what they do to make tax time easier.

  • Netflix in talks to buy Egyptian Theatre in Hollywood
    Yahoo Finance Video12 days ago

    Netflix in talks to buy Egyptian Theatre in Hollywood

    Netflix is in early talks to buy Hollywood's Egyptian Theatre, which would be the streaming giant's first movie theatre acquisition. Yahoo Finance's Melody Hahm, Julia La Roche, and Myles Udland discuss what this acquisition means for Netflix and viewers.

  • Walmart adds thousands of new robots to stores
    Yahoo Finance Video13 days ago

    Walmart adds thousands of new robots to stores

    Walmart is doubling down on robot janitors, adding thousands of robots to their stores. Yahoo Finance's Zack Guzman, Julia La Roche, and Heidi Chung are joined by Danielle DiMartino Booth, Quill Intelligence CEO and Director of Intelligence, to discuss.